© 1997 by Oxford University Press
Journal Of The National Cancer Institute, Vol 89, 1036-1044, Copyright © 1997 by Oxford University Press
C Gomez-Manzano, J Fueyo, AP Kyritsis, TJ McDonnell, PA Steck, VA Levin and WK Yung
BACKGROUND: Alterations of the p53 (also called TP53) gene are one of the
most common abnormalities in gliomas. We have previously reported that
restoration of wild-type p53 protein function in glioma cells results in
programmed cell death (apoptosis). Since p53 functions are mediated by
genes that directly control the tumor suppressor effect of the p53 protein,
understanding the relationship between p53 and p53- related genes in glioma
cells will aid in the design of more rational treatment strategies for
brain tumors. PURPOSE: We conducted this study to examine the timing of the
p53-mediated events preceding apoptosis. More specifically, we undertook
this work to characterize the genetic and cell cycle-related factors that
may increase the resistance of glioma cells to p53-induced apoptosis.
METHODS: Two human glioma cell lines (U-251 MG and U-373 MG) that express
mutant p53 protein and two (U-87 MG and EFC-2) that express wild-type p53
protein were used. Replication-deficient adenovirus was utilized as an
expression vector to transfer exogenous p53 and p21 complementary DNAs into
the glioma cells; control cells were infected with the viral expression
vector alone. To monitor gene transfer and the expression of exogenous
genes (as well as the expression of endogenous genes), we used western blot
analyses and immunohistochemistry analyses. Flow cytometry studies of
cellular DNA content were performed to determine the cell cycle phenotype
of the glioma cells before and after treatment. RESULTS: p53- mediated
apoptosis was preceded by elevation in the levels of the p21 (cell
cycle-related) and Bax (apoptosis-related) proteins. In addition, cell
cycle analyses showed that glioma cells were arrested in the G2 phase
before undergoing cell death. Transfer of p21 induced a G2 block but did
not induce apoptosis. Moreover, coexpression of p21 and p53 prevented
glioma cells from undergoing apoptosis. Expression of exogenous p53 in
wild-type p53 cells did not induce elevation of Bax levels, arrest in G2
phase, or apoptosis. CONCLUSIONS AND IMPLICATIONS: Our data confirmed the
ability of wild-type p53 to induce apoptosis in p53 mutant glioma cells. In
addition, our results document that p21 plays a role in protecting cells
from p53-mediated programmed cell death and suggest that p53-mediated
apoptosis and p21 induction may represent, at least in certain cases,
opposite signals. Finally, our data suggest that over expression of p21 in
gliomas may be related to resistance to treatments that induce apoptosis.
ARTICLES
Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis
Department of Neuro-Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Nakamizo, T. Amano, W. Zhang, X.-Q. Zhang, L. Ramdas, T.-J. Liu, B. N. Bekele, T. Shono, T. Sasaki, W. F. Benedict, et al. Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosis Neuro-oncol, January 1, 2008; 10(3): 275 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Alonso, M. Cascallo, C. Gomez-Manzano, H. Jiang, B. N. Bekele, A. Perez-Gimenez, F. F. Lang, Y. Piao, R. Alemany, and J. Fueyo ICOVIR-5 Shows E2F1 Addiction and Potent Antiglioma Effect In vivo Cancer Res., September 1, 2007; 67(17): 8255 - 8263. [Abstract] [Full Text] [PDF] |
||||
![]() |
O.-H. Lee, J. Xu, J. Fueyo, G. N. Fuller, K. D. Aldape, M. M. Alonso, Y. Piao, T.-J. Liu, F. F. Lang, B. N. Bekele, et al. Expression of the Receptor Tyrosine Kinase Tie2 in Neoplastic Glial Cells Is Associated with Integrin {beta}1-Dependent Adhesion to the Extracellular Matrix Mol. Cancer Res., December 1, 2006; 4(12): 915 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Alonso, J. Fueyo, J. W. Shay, K. D. Aldape, H. Jiang, O.-H. Lee, D. G. Johnson, J. Xu, Y. Kondo, T. Kanzawa, et al. Expression of Transcription Factor E2F1 and Telomerase in Glioblastomas: Mechanistic Linkage and Prognostic Significance J Natl Cancer Inst, November 2, 2005; 97(21): 1589 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Lang, J. M. Bruner, G. N. Fuller, K. Aldape, M. D. Prados, S. Chang, M. S. Berger, M. W. McDermott, S. M. Kunwar, L. R. Junck, et al. Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results J. Clin. Oncol., July 1, 2003; 21(13): 2508 - 2518. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fueyo, R. Alemany, C. Gomez-Manzano, G. N. Fuller, A. Khan, C. A. Conrad, T.-J. Liu, H. Jiang, M. G. Lemoine, K. Suzuki, et al. Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway J Natl Cancer Inst, May 7, 2003; 95(9): 652 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shono, P. J. Tofilon, T. S. Schaefer, D. Parikh, T.-J. Liu, and F. F. Lang Apoptosis Induced by Adenovirus-mediated p53 Gene Transfer in Human Glioma Correlates with Site-specific Phosphorylation Cancer Res., February 1, 2002; 62(4): 1069 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gomez-Manzano, P. Mitlianga, J. Fueyo, H.-Y. Lee, M. Hu, K. B. Spurgers, T. L. Glass, D. Koul, T.-J. Liu, T. J. McDonnell, et al. Transfer of E2F-1 to Human Glioma Cells Results in Transcriptional Up-Regulation of Bcl-2 Cancer Res., September 1, 2001; 61(18): 6693 - 6697. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Naumann, S. Kugler, H. Wolburg, W. Wick, G. Rascher, J. B. Schulz, E. Conseiller, M. Bahr, and M. Weller Chimeric Tumor Suppressor 1, a p53-derived Chimeric Tumor Suppressor Gene, Kills p53 Mutant and p53 Wild-type Glioma Cells in Synergy with Irradiation and CD95 Ligand Cancer Res., August 1, 2001; 61(15): 5833 - 5842. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Cerrato, W.K. A. Yung, and T.-J. Liu Introduction of mutant p53 into a wild-type p53-expressing glioma cell line confers sensitivity to Ad-p53-induced apoptosis Neuro-oncol, April 1, 2001; 3(2): 113 - 122. [Abstract] [PDF] |
||||
![]() |
M. Nozaki, M. Tada, H. Kobayashi, C.-L. Zhang, Y. Sawamura, H. Abe, N. Ishii, and E. G. Van Meir Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression Neuro-oncol, April 1, 1999; 1(2): 124 - 137. [Abstract] [PDF] |
||||
![]() |
M. J. Frederick, P. R. Holton, M. Hudson, M. Wang, and G. L. Clayman Expression of Apoptosis-related Genes in Human Head and Neck Squamous Cell Carcinomas Undergoing p53-mediated Programmed Cell Death Clin. Cancer Res., February 1, 1999; 5(2): 361 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. G. Shu, M. M. Kim, P. Chen, F. Furman, C. M. Julin, and M. A. Israel The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21BAX expression PNAS, November 24, 1998; 95(24): 14453 - 14458. [Abstract] [Full Text] [PDF] |
||||






